Literature DB >> 12819254

Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem.

Peter Stenvinkel1, Roberto Pecoits-Filho, Bengt Lindholm.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12819254     DOI： 10.1097/01.asn.0000069165.79509.42

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  40 in total

Review 1.  Functional neural-bone marrow pathways: implications in hypertension and cardiovascular disease.

Authors:  Jasenka Zubcevic; Monica M Santisteban; Teresa Pitts; David M Baekey; Pablo D Perez; Donald C Bolser; Marcelo Febo; Mohan K Raizada
Journal:  Hypertension       Date:  2014-03-31       Impact factor: 10.190

Review 2.  Statin therapy in peritoneal dialysis patients: effects beyond lipid lowering.

Authors:  Kosmas I Paraskevas
Journal:  Int Urol Nephrol       Date:  2007-12-08       Impact factor: 2.370

Review 3.  Cardiovascular complications in pediatric end-stage renal disease.

Authors:  Rulan S Parekh; Samuel S Gidding
Journal:  Pediatr Nephrol       Date:  2004-12-15       Impact factor: 3.714

Review 4.  Cardiovascular co-morbidity in chronic kidney disease: Current knowledge and future research needs.

Authors:  Hudaifa Alani; Asad Tamimi; Nihad Tamimi
Journal:  World J Nephrol       Date:  2014-11-06

5.  The link between bone and coronary calcifications in CKD-5 patients on haemodialysis.

Authors:  Gulay Asci; Ercan Ok; Recep Savas; Mehmet Ozkahya; Soner Duman; Huseyin Toz; Meral Kayikcioglu; Adam J Branscum; Marie-Claude Monier-Faugere; Johann Herberth; Hartmut H Malluche
Journal:  Nephrol Dial Transplant       Date:  2010-08-13       Impact factor: 5.992

6.  Relationship between serum fibroblast growth factor-23 level and mortality in chronic hemodialysis patients.

Authors:  Himiko Sugimoto; Tetsuya Ogawa; Yuko Iwabuchi; Kuniaki Otsuka; Kosaku Nitta
Journal:  Int Urol Nephrol       Date:  2013-01-25       Impact factor: 2.370

7.  Elevated serum macrophage migration inhibitory factor (MIF) concentrations in chronic kidney disease (CKD) are associated with markers of oxidative stress and endothelial activation.

Authors:  Annette Bruchfeld; Juan J Carrero; Abdul R Qureshi; Bengt Lindholm; Peter Barany; Olof Heimburger; Maowen Hu; Xinchun Lin; Peter Stenvinkel; Edmund J Miller
Journal:  Mol Med       Date:  2009-12-08       Impact factor: 6.354

Review 8.  Cholesterol Metabolism in CKD.

Authors:  Allison B Reiss; Iryna Voloshyna; Joshua De Leon; Nobuyuki Miyawaki; Joseph Mattana
Journal:  Am J Kidney Dis       Date:  2015-09-01       Impact factor: 8.860

9.  A pilot randomized crossover trial assessing the safety and short-term effects of pomegranate supplementation in hemodialysis patients.

Authors:  Matthew B Rivara; Rajnish Mehrotra; Lori Linke; John Ruzinski; T Alp Ikizler; Jonathan Himmelfarb
Journal:  J Ren Nutr       Date:  2014-09-11       Impact factor: 3.655

10.  Associations between oxidized LDL to LDL ratio, HDL and vascular calcification in the feet of hemodialysis patients.

Authors:  Won Suk An; Seong-Eun Kim; Ki-Hyun Kim; Hae-Rahn Bae; Seo-Hee Rha
Journal:  J Korean Med Sci       Date:  2009-01-28       Impact factor: 2.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.